Quarterly report · Q1
3840.TEDINET S100P1D5
Period2022-04-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥534m | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥580m | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | −¥32m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | −¥162m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | −¥43m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥737m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥205m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥43m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥205m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥43m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥746m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥205m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥43m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | −¥205m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥1.3bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥1.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.3bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥307m | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥802m | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥968m | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥470m | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥839m | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥172m | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥345m | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-1 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.95 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.16 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.2% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 23
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥200,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥200,000 |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥27m |
| jpcrp040300-q1r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥534m |
| jpcrp040300-q1r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥534m |
| jpcrp040300-q1r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥12m |
| jpcrp040300-q1r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥200,000 |
| jpcrp040300-q1r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥200,000 |
| jpcrp040300-q1r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥17m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥534m |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥534m |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥200,000 |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | −¥5m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥802,000 |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2021-06-30 | −¥802,000 |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥25m |
| jpcrp040300-q1r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥580m |
| jpcrp040300-q1r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥580m |
| jpcrp040300-q1r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥124m |
| jpcrp040300-q1r_E05674-000Sustainable Regenerative Medicine Related Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥12m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥580m |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥580m |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | −¥137m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 308
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |